With a focus on large-scale production, our state-of-the-art facilities are equipped with the latest advancements in biotechnology, enabling us to meet the growing demand for molecular diagnostic solutions worldwide. Our in vitro diagnostic reagent products play a pivotal role in the detection of infectious diseases, personalized cancer medication, and genetic disorders. Covering a spectrum of medical disciplines, including respiratory, digestive, blood, endocrine, nervous, and reproductive urinary systems, our solutions encompass diagnostics for infectious and malignant diseases alike.

Afton Diagnostics is not just a company; we are a driving force in the quest for improved healthcare outcomes. Through strategic alliances and partnerships with leading medical institutions, we actively collaborate in the development of groundbreaking diagnostic technologies. These partnerships amplify our research capabilities and enable us to stay at the forefront of molecular diagnostics.

Our commitment extends beyond the laboratory walls. We are deeply invested in addressing pressing global health concerns, including the threat posed by biological agents. Leveraging our expertise, we contribute to the development of technologies for rapid biothreat detection and monitoring. By harnessing the power of molecular diagnostics, we strive to provide early warning systems and effective countermeasures against biological threats.

At Afton Diagnostics, innovation is at the heart of everything we do. We are driven by a shared vision of revolutionizing healthcare through groundbreaking molecular diagnostic solutions. Join us on this transformative journey as we continue to push the boundaries of scientific discovery and redefine the future of diagnostics.